In the first installement of our Q&A series, Dr Deirdre Kelly provides us with a comprehensive overview of the cancer immunotherapy market.
Oncology is a rapidly growing therapy area, both in terms of me-too and first-in-class products, with the first-in-class segment of the pipeline growing strongly in recent years.
Britain's historic vote to leave the European Union means changes are ahead for the UK pharma industry. The decision has created an air of uncertainty in British and European markets. Here we look at the biggest uncertainties facing UK pharma post-Brexit.
As scientists learn more about the various types of cancer, they develop new and innovative ways to treat and prevent the disease. The following blog will explore some of the cancer-specific innovations that have been making headlines in recent months.
Professor Paula Hammond, at a recent TED talks conference, explained how a nanoparticle one-hundredth the size of a human hair could treat the most drug-resistant cancers.